News
Pfizer (PFE 0.77%) made a fortune thanks to its work in the COVID-19 market. In 2022, it became the first company in the ...
4h
Zacks Investment Research on MSNPfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on ItPfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...
Pfizer’s recent earnings report dazzled investors, but not everything sparkles like it seems. Unusual items worth ₹1.7b ...
Many investors turn to Benjamin Graham's so-called “Graham number” to calculate the fair price of a stock. The Graham number ...
Pfizer is an attractive value play, trading at a significant discount despite strong profitability and growth fundamentals ...
These four quality stocks trading at or near their 52-week lows come with stellar dividends that could be massive bargains ...
There are instances where high-yielding stocks can simply be great deals. Three stocks that pay at least 6% and don't look ...
Pfizer’s stock surged up to 11 percent after the pharma giant reported a robust 85 percent year-on-year rise in net profit ...
Gujarat Gas Limited, Quess Corp, Power Finance Corporation, and Eris Lifesciences Limited will also report their quarterly ...
Pfizer beats EPS estimates for the 12th quarter. Explore PFE's oncology success, cost-cutting impact, and why it's rated a ...
11d
Zacks Investment Research on MSNPfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should KnowPfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
Investing.com -- Moody’s Ratings has assigned an A2 rating to Pfizer Netherlands International Finance B.V. (PNIF BV), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results